Revolver Therapeutics targets transcription factors that are hard to reach with conventional drugs and antibodies
Jody Mason’s favourite Beatles album is ‘Revolver’. Just as the band’s seventh album marked a radical musical shift, Mason and his colleagues have developed ‘a revolutionary new technique’ to screen and evolve therapeutic peptides to target ‘undruggable’ proteins. This technology is the basis of the University of Bath spin-out co-founded by Mason, Revolver Therapeutics.